news

news

News from the Lab (news.myScience.ch)

  • News from the Lab’ is a selection of scientific works that are significant or interesting for a broad readership. 
  • The selection of news is made by the team of myScience.ch. There is no right to be published or automatic publishing.
  •  RSS Feeds (Add this page to your bookmarks)
« BACK

Health



Results 1 - 20 of 485.
1 2 3 4 5 ... 25 Next »


Life Sciences - Health - 20.06.2022
Protein changes in the liquor indicate inflammatory processes in the brain
Alzheimer's, Parkinson's and other neurodegenerative diseases are associated with inflammatory processes in the brain. German researchers have succeeded in identifying a group of proteins in the liquor that could provide information about such inflammatory processes. As so-called biomarkers, the proteins could help to better understand disease processes in the future and to test the effect of potential drugs against brain inflammation.

Life Sciences - Health - 17.06.2022
Cell Biology: Diversity of centrosomes
Cell Biology: Diversity of centrosomes
Scientists from LMU and Helmholtz Munich have gained new insights into the human centrosome, whose malfunction is linked to many neurodevelopmental disorders. The centrosome is the organelle responsible for the organization of the cytoskeleton during cell division, an essential function in organisms from yeast to humans.

Health - Life Sciences - 15.06.2022
Custom-fit bacterial blockers
Custom-fit bacterial blockers
Similar to vaccines against the coronavirus, RNA-based antibiotics could decisively advance medicine. Research teams from Würzburg have investigated the requirements they must fulfill to achieve this. In the fight against the corona pandemic, mRNA-based drugs have impressively demonstrated their capabilities.

Health - Life Sciences - 10.06.2022
Thanks to umbilical cord stem cells: First successful treatment of severe pulmonary hypertension
Thanks to umbilical cord stem cells: First successful treatment of severe pulmonary hypertension
Hannover Medical School doctors successfully treat three-year-old girl. Clinical researchers at Hannover Medical School (MHH) have succeeded for the first time worldwide in stopping the usually fatal course of the disease in severe pulmonary hypertension thanks to a novel therapeutic approach. A three-year-old girl suffering from so-called pulmonary arterial hypertension (PAH) was treated for six months a total of five times with mesenchymal stem cell products obtained from a human umbilical cord.

Health - Innovation - 02.06.2022
3D printed, bioinspired heart valves
3D printed, bioinspired heart valves
Researchers have developed 3D printed artificial heart valves designed to allow a patient's own cells to form new tissue. To form these scaffolds using melt electrowriting - an advanced additive manufacturing technique - the team has created a new fabrication platform that enables them to combine different precise, customized patterns and hence to fine-tune the scaffold's mechanical properties.

Health - Pharmacology - 01.06.2022
Misperceptions about doctor's trust in Covid-19 vaccines influence vaccination rate
Misperceptions about doctor’s trust in Covid-19 vaccines influence vaccination rate
Informing people about the strong positive consensus among doctors persistently leads to increases in Covid-19 vaccinations How to increase vaccination rates by autumn, without any compulsion is shown by an international research team including the Max Planck Institute for Tax Law and Public Finance.

Social Sciences - Health - 31.05.2022
Healthy development thanks to older siblings
Healthy development thanks to older siblings
If expectant mothers are exposed to stress their child can develop behavioural problems - but this is less often the case for children with siblings During the first years of their lives, children develop the cognitive, social and emotional skills that will provide the foundations for their lifelong health and achievements.

Health - Pharmacology - 31.05.2022
Drug combination triples survival time with blood cancer
Drug combination triples survival time with blood cancer
MHH involved in international study on acute myeloid leukaemia (AML) Acute myeloid leukaemia (AML) is a malignant disease in which the precursor cells of the haematopoietic system multiply uncontrollably. This form of blood cancer is caused by genetic changes in the bone marrow that occur in the course of life.

Health - Pharmacology - 31.05.2022
Vaccination strategy can be optimised with computer model
HU research team simulates COVID-19 outbreaks with virtual agents A new model for simulating COVID-19 outbreaks helps to develop the right strategy for herd immunity for every municipality and city - even in the event of vaccine shortages. For, even after two years of the pandemic, countries, municipalities and cities are still experiencing severe COVID-19 outbreaks.

Life Sciences - Health - 31.05.2022
How invading pathogens switch off plant cells' defenses
How invading pathogens switch off plant cells’ defenses
Many disease-causing bacteria are able to inhibit the defense mechanisms in plants and thus escape dissolution by the plant cell, a process known as xenophagy. Animal and human cells have a similar mechanism whereby the cell's defenses -eat- invading bacteria - yet some bacteria can inhibit the process.

Health - Chemistry - 30.05.2022
Multi-functional bandage helps wounds to heal
Multi-functional bandage helps wounds to heal
Researchers at the Technical University of Munich (TUM) have developed a film that not only protects wounds similar to the way a bandage does, but also helps wounds to heal faster, repels bacteria, dampens inflammation, releases active pharmaceutical ingredients in a targeted manner and ultimately dissolves by itself.

Health - Computer Science - 27.05.2022
Same symptom - different cause?
Same symptom - different cause?
Machine learning is playing an ever-increasing role in biomedical research. Scientists at the Technical University of Munich (TUM) have now developed a new method of using molecular data to extract subtypes of illnesses. In the future, this method can help to support the study of larger patient groups.

Health - Sport - 25.05.2022
Link between exercise intensity and risk of infection
Link between exercise intensity and risk of infection
Until now there has been no clarity on how exercise intensity affects the emission and concentration of aerosol particles in exhaled air. With a new experimental setup, a Munich research team has shown that aerosol emissions increase exponentially with intense physical exertion - so that indoor sporting activities result in a higher risk of infectious diseases such as COVID.

Health - Life Sciences - 25.05.2022
A potential fountain of youth for the immune system
05/25/2022 In old age, the performance of the immune system decreases, and older people are more susceptible to infections. Research teams from Würzburg and Freiburg have now discovered an approach that could be used to slow down this process. The corona pandemic has made it clear: Older people are more susceptible to infections, suffer from more severe infectious diseases than young people, and they take significantly longer to recover.

Health - Life Sciences - 25.05.2022
Secrets of thymus formation revealed
Secrets of thymus formation revealed
Max Planck researchers identify epithelial stem cells that control the growth of the thymus at different stages of life Many immune cells crucial for our immune system develop in a small organ next to our heart: the thymus. With age, however, the thymus shrinks, and the number of effective immune cells declines.

Chemistry - Health - 20.05.2022
Mini-fuel cell generates electricity using the body’s sugar
Glucose energy source for medicinal implants and sensors Mini-fuel cell generates electricity using the body's sugar Glucose is the most important energy source in the human body. Scientists at the Technical University of Munich (TUM) and the Massachusetts Institute of Technology (MIT) now want to use the body's sugar as an energy source for medicinal implants.

Health - Life Sciences - 19.05.2022
New method revolutionizes cancer diagnosis
"Deep Visual Proteomics" technology provides cell-specific, protein-based information and helps to analyze cancer diseases How does cancer arise? How does cellular composition influence tumor malignancy? These questions are profound and challenging to answer, but are crucial to understand the disease and find the right cure.

Health - Life Sciences - 18.05.2022
On the trail of urinary tract infections
On the trail of urinary tract infections
05/18/2022 The German government is providing about 2.4 million Euros for a new research group in infectious diseases at JMU Würzburg. Dr. Carmen Aguilar will use this grant to search for new therapeutic approaches against one of the most common and recurrent bacterial infections. About every second woman gets a urinary tract infection once in her life, the cause for which is most often the uropathogenic bacterium Escherichia coli (UPEC).

Health - Life Sciences - 13.05.2022
'Growing end' of inflammation discovered
’Growing end’ of inflammation discovered
Researchers from the Universities of Bonn and Cologne observe how the danger sensor NLRP3 lengthens itself like a thread Redness, swelling, pain - these are signs of inflammation. It serves to protect the body from pathogens or foreign substances. Researchers from the Universities of Bonn and Cologne were able to show that inflammatory reactions of an important sensor protein proceed in a specific spatial direction.

Health - Life Sciences - 12.05.2022
A repair program for the heart
Following a heart attack, the human body is incapable of repairing lost tissue due to the heart's inability to generate new muscle. However, treatment with heart progenitor cells could result in the formation of functional heart cells at injured sites. This new therapeutic approach is introduced by an international team.
1 2 3 4 5 ... 25 Next »